Latest MMRV vaccine Stories
OAKLAND, Calif., June 28 /PRNewswire/ -- The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and the varicella (V) vaccine for chicken pox, according to a Kaiser Permanente Division of Research study appearing online in the journal Pediatrics.
By Anne Johns A Magazine editor facing deafness as a result of childhood measles has urged parents to protect their children against the disease.
In a warning letter sent to Merck & Coâ€™s CEO Richard Clark, and released publicly Wednesday, the Food and Drug Administration (FDA) ordered the company to rectify numerous manufacturing deficiencies at its main vaccine plant in West Point, Pa., just outside Philadelphia.
The results of a new study presented Wednesday at a meeting of the Advisory Committee on Immunization Practices said children suffer higher rates of fever-induced convulsions after receiving the Merck combination vaccine ProQuad instead of two separate shots.
NEW YORK (Reuters) - Merck & Co. Inc. on Tuesday said U.S. regulators have approved its combination vaccine to protect children 12 months to 12 years of age against measles, mumps, rubella and chickenpox.
- A woman chauffeur.
- A woman who operates an automobile.